دورية أكاديمية
Safety and Efficacy of Open-label Subcutaneous Ixekizumab Treatment for 48 Weeks in a Phase II Study in Biologic-naive and TNF-IR Patients with Rheumatoid Arthritis.
| العنوان: | Safety and Efficacy of Open-label Subcutaneous Ixekizumab Treatment for 48 Weeks in a Phase II Study in Biologic-naive and TNF-IR Patients with Rheumatoid Arthritis. |
|---|---|
| المؤلفون: | Genovese, Mark C., Braun, Daniel K., Erickson, Janelle S., Berclaz, Pierre-Yves, Banerjee, Subhashis, Heffernan, Michael P., Carlier, Hilde |
| المصدر: | Journal of Rheumatology; Feb2016, Vol. 43 Issue 2, p289-297, 9p |
| قاعدة البيانات: | Supplemental Index |
| تدمد: | 0315162X |
|---|---|
| DOI: | 10.3899/jrheum.140831 |